GILD

Gilead Sciences (GILD) Stock Moves 1.40%: What You Should Know

Here's How Much $1000 Invested In Gilead Sciences 5 Years Ago Would Be Worth Today

Why Morgan Stanley likes Gilead’s HIV prevention play

Gilead Sciences Inc's Dividend Analysis

If You Invested $100 In Gilead Sciences Stock 20 Years Ago, You Would Have This Much Today

Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights

Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?

Is Gilead Sciences Stock Outperforming the S&P 500?

Gilead Sciences (GILD) Wins EU Trodelvy Approval, Is The Stock Fully Priced?

Gilead (GILD) Stock Looks Undervalued After A 147% Five Year Run

Gilead Sciences Has Snapped Out of Its Slump -- and 1 Catalyst Is Doing Most of the Heavy Lifting

Can Gilead's Efforts to Develop New Treatments Solidify HIV Franchise?

ETFs Investing in Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S Stocks

Gilead (GILD) Will Bring New HIV Data And A Merck Regimen To AIDS 2026

ETFs Investing in Gilead Sciences, Inc. Stocks